Kana Enomoto is director of brain health for the McKinsey Health Institute and co-leads McKinsey’s behavioral health domain where she integrates knowledge of mental health and substance use policy and research perspectives with current trends to enhance the impact of commercial and public sector investments in behavioral health. Kana’s current responsibilities include helping governments expand access to behavioral health services for adults and children across government-funded and private insurance. She also supports a national partnership in the United States to strengthen community-based suicide prevention and crisis systems. Kana provides strategic guidance on global policy change to facilitate consumer access to prevention, treatment, and recovery services. She also serves as an advisor to payors and other investors considering emerging opportunities in the behavioral health space.
Announcing New Members of Concordia’s Advisory Board
Concordia is pleased to announce the appointment of a distinguished group of global leaders to its Advisory Board. Representing a diverse range of sectors, geographies, and areas of expertise, these individuals bring
